HAKU KAHOANO: Open Payments
NPI 1073714937 · JAMESTOWN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 27 payments from 13 companies in 2025. Trend: 2023 $264 · 2024 $553 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Lilly USA, LLC | 3 | $52 |
| Novo Nordisk Inc | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Corcept Therapeutics | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Belbuca, MOUNJARO, FARXIGA, CAPLYTA, Wegovy, VOQUEZNA, Korlym, REXULTI.
Industry payments across CA — which companies pay providers there.
